FDA campaign H-0653-2026
Class IHazard
FDA analysis revealed the presence of undeclared sildenafil and Tadalafil
Distribution
New Jersey
REKALLD area-alert coverage: NJ (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.